ng-nitroarginine methyl ester has been researched along with Cerebral Arteriosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, Y; Du, H; Geng, X; Ji, X; Li, F; Shen, J; Stevenson, J; Wang, S; Yang, J; Yin, C | 1 |
Baraghis, E; Bélanger, É; Bolduc, V; Drouin, A; Ferland, G; Fernandes, P; Gillis, MA; Hamel, E; Lesage, F; Thorin, E; Thorin-Trescases, N; Villeneuve, L | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Cerebral Arteriosclerosis
Article | Year |
---|---|
A new clinically relevant model for intracranial atherosclerosis in rats.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Basilar Artery; Body Weight; Carotid Artery, Internal; Diet, High-Fat; Disease Models, Animal; Eating; Enzyme Inhibitors; Intracranial Arteriosclerosis; Lipids; Male; Middle Cerebral Artery; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2016 |
Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice.
Topics: Animals; Apolipoprotein B-100; Blood Pressure; Brain; Catechin; Cerebral Arteries; Cerebrovascular Circulation; Cholesterol; Heart Rate; Intracranial Arteriosclerosis; Learning; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Triglycerides; Vasodilation; Vasodilator Agents | 2011 |